Skip to main content
. 2020 Feb 5;12(3):2246–2260. doi: 10.18632/aging.102743

Figure 2.

Figure 2

IL-1β treatment reduces NPC viability. (A) Viability of NPCs treated with IL-1β. *p<0.05 (B) Viability of NPCs treated with IL-1β and Genistein. *p<0.05.